Neurosurgeons team in Germany has used an optical biopsy system to identify cancerous brain and spinal tumors, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.
Confocal Laser Endomicroscopy (CLE) has the potential to intraoperatively detect and characterize tumor cells, providing immediate diagnosis without the need for frozen sections. They used the Cellvizio optical biopsy technology developed by the French company Mauna Kea Technology, combined with support from Siemens. It is assumed that a subsequent routine use of CLE-assisted surgery will significantly improve both the diagnosis and the treatment of tumorous processes and can offer patients a significantly increased survival rate and quality of life. This technique provides a qualitatively new contribution to the diagnosis, treatment, and follow-up of tumor diseases.